[Report] Cracking the Code of Oncology Commercialization

Where Science Meets the Soul of Storytelling

The pace of oncology innovation is staggering. Are your strategies keeping up? 

More than 50 new cancer medicines were approved in the past year alone. Clinical guidelines are evolving. Community oncology clinics, where around 80 percent of cancer patients are treated, are under increasing pressure to make faster, smarter decisions. 

Just in time for ASCO 2025, this thought leadership report arrives as the broader oncology community comes together to spotlight breakthroughs, challenge convention and chart the future of cancer care. As thousands of researchers, clinicians and biopharma leaders convene in Chicago, the real question isn’t just what’s new; it’s how to communicate it effectively in a landscape where innovation moves at the speed of light, and so does the attention of your audiences. 

Real Chemistry’s new report reveals how to meet this moment. 

Backed by deep audience intelligence, AI-powered analytics, and cross-functional insights from our medical communications, market access, commercial, communications and creative teams, this is your strategic guide to not just launching – but lasting. 

What You’ll Learn: 

• Precision demands personalization. From novel biomarkers like ctDNA, HER2 alterations, and TROP2 expression to advanced testing methods such as NGS and computational pathology, scientific progress is accelerating. Commercial strategies must evolve alongside these advancements to stay relevant. 
• The oncology care team is changing. From oncologists and APPs to pathologists, radiologists, and financial navigators, today’s treatment decisions are made by multidisciplinary teams under pressure. Understanding each role, and how to engage them meaningfully, is key to driving behavior change. 
• Messaging must resonate, not just inform. Fragmented or inconsistent communication can stall promising therapies. Success hinges on alignment across commercial and medical teams, anchored by a clear, credible value proposition that connects clinically and emotionally. 
• Data isn’t enough. Value must be clear. Payers are demanding more than efficacy. From real-world outcomes to operational logistics, value propositions must address the total picture – clinical, economic and practical – to ensure access and adoption. 
• Impact happens when stakeholders feel seen. Using proprietary segmentation and AI-driven modeling, Real Chemistry uncovers how key oncology stakeholders think, act, and engage with content, and enabling brands to show up in ways that feel relevant, timely and human. 

Download the Report

Discover how science-informed strategy and human-centered storytelling can change the trajectory of your oncology brand, just in time for the biggest oncology meeting of the year.

Download

Real Chemistry at ASCO 2025 + Check Out More of Our Oncology-Focused POVs

Real Chemistry will be joining clients in Chicago again this year to experience the groundbreaking advances in oncology that will be showcased. By innovating across boundaries, together we are working to bring down barriers to access and make care more equitable, convenient, and efficient for patients worldwide.

Ahead of this year’s event, we invite you to connect with our team and check out more of our recent oncology-focused POVs here.